 |
Xcellerex named to Inc. Magazine's list of fastest growing companies. more Xcellerex introduces 10 Liter XDR-10 Single-Use Bioreactor more Xcellerex Announces Sale of FlexFactory Bioproduction Line to R-Pharm for New Manufacturing Facility in Russia more Xcellerex® and Gallus BioPharmaceuticals Announce Biomanufacturing Collaboration. more First clinical trial results of Xcellerex inactivated vaccine against yellow fever published in New England Journal of Medicine. more Xcellerex Welcomes ISPE Japan Dignitaries for Tour of New FlexFactory® Biomanufacturing Facility. more Xcellerex recognized by Invensys with 2010 Productivity Excellence Award. more GreenVax Selects Xcellerex XDR Single-Use Bioreactors for New Vaccine and Biotherapeutics Program. more Xcellerex Signs Memorandum of Understanding with SK Chemicals to Commercialize SK-Developed Vaccines with FlexFactory® Platform. more Xcellerex Announces Appointment of Guy Broadbent as President and Chief Executive Officer. more Xcellerex announces groundbreaking for new FlexFactory facility. more Xcellerex and partners announce completion of successful test of Rapid Production of Swine Flu H1 Hemagglutinin. more 
|
 |
